Full‑Body Scans for Cancer Detection: Benefits, Risks, and What the Experts Say

Some imaging centers now market full‑body scans as an “early‑detection” service for people who feel perfectly healthy. While the idea sounds appealing, leading health agencies—including the U.S. Food and Drug Administration (FDA) and the American Cancer Society—do not endorse these scans as a cancer‑screening tool. Current research indicates that the potential harms outweigh any unproven benefit.

What is a full‑body scan?

A full‑body scan is most often a computed tomography (CT) exam that images the body from just below the chin to the pelvis (or sometimes the entire torso). Magnetic resonance imaging (MRI) and positron‑emission tomography (PET) can also be used, but CT remains the most common because of speed and availability. Clinically, such scans are ordered to assess the extent of trauma, internal bleeding, or to monitor known cancer spread.

Why it is not a recommended cancer‑screening test

Screening programs aim to detect disease early in asymptomatic people while minimizing false results and adverse effects. Full‑body scans fail to meet these criteria for several reasons:

• Radiation exposure. A single CT or PET full‑body exam delivers a dose of ionizing radiation comparable to several hundred chest X‑rays, which modestly raises a person’s lifetime cancer risk.
• False‑positive findings. Incidental abnormalities are common; most are benign, yet they trigger additional imaging, biopsies, anxiety, and medical costs.
• False‑negative findings. Small or early‑stage tumors can be missed, giving a false sense of security that may delay appropriate symptom‑based evaluation.
• Lack of evidence. Large, population‑based studies have not demonstrated that routine full‑body scanning reduces cancer mortality. Consequently, the FDA and major medical societies do not recommend it for average‑risk adults.

How it compares with proven screening tests

Established screenings—such as mammography for breast cancer and colonoscopy for colorectal cancer—have undergone rigorous trials that show a clear mortality benefit. Although they also produce occasional false positives, the overall benefit–risk balance is well documented, and they do not involve high‑dose radiation (except low‑dose CT for high‑risk lung‑cancer screening, which targets a limited area).

What the procedure looks like

A full‑body scan is an outpatient exam that typically takes about 20 minutes and does not require anesthesia. The steps are:

1. Change into a hospital gown and remove metal objects.
2. Lie on a padded table that slides into the scanner’s tunnel.
3. If a PET scan is performed, a small amount of radioactive tracer may be injected.
4. The scanner rotates around you, capturing cross‑sectional images.
5. You must remain still, but you can speak with the technologist.
6. The entire study usually finishes within 20 minutes.

Cost and insurance coverage

Elective full‑body scans are generally not covered by insurance unless a physician deems them medically necessary for injury evaluation or cancer staging. Prices reported online range from roughly $500 to several thousand dollars, depending on the technology, location, and facility.

Current research and future directions

Investigators are exploring whether targeted full‑body imaging could benefit people at very high risk for specific cancers (e.g., heavy smokers for lung cancer). To date, no large‑scale trial has proven a mortality benefit, and the consensus remains that routine full‑body scanning is not a suitable screening method.

In summary, while a full‑body scan can be a valuable diagnostic tool in certain clinical situations, it is not an effective or recommended strategy for cancer screening in healthy, asymptomatic individuals. The potential for radiation‑induced harm, unnecessary follow‑up procedures, and false reassurance outweighs any unproven advantage.